A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)

Merck Sharp & Dohme (MSD)

Status and phase: Completed; Phase 3

Conditions: Postoperative Pain

Treatments: Drug: Comparator: oxycodone and acetaminophen; Drug: MK0966, rofecoxib

Study type: Interventional

Funder types: Industry

Identifiers

NCT00092313

2004_067

0966-182

MK0966-182

Details and patient eligibility

About

The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery.

Full description

The duration of treatment is 24 hours.

Enrollment: 271 patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Impaction of a molar tooth requiring removal

Exclusion criteria

• Known allergy to the study drugs

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind